These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 16854496)

  • 1. Science, medicine and... the markets.
    Pawlotsky JM
    J Hepatol; 2006 Sep; 45(3):341-2. PubMed ID: 16854496
    [No Abstract]   [Full Text] [Related]  

  • 2. A changing drug supply.
    Nature; 2007 Feb; 445(7127):460. PubMed ID: 17268432
    [No Abstract]   [Full Text] [Related]  

  • 3. Alterations in processes and priorities needed for new drug development.
    Wilson JF
    Ann Intern Med; 2006 Nov; 145(10):793-6. PubMed ID: 17116936
    [No Abstract]   [Full Text] [Related]  

  • 4. [The economics of therapeutic investigations (author's transl)].
    Poisvert M
    Anesth Analg (Paris); 1980; 37(9-10):619-20, 623-6. PubMed ID: 7469079
    [No Abstract]   [Full Text] [Related]  

  • 5. Innovative drug R&D in China.
    Qi J; Wang Q; Yu Z; Chen X; Wang F
    Nat Rev Drug Discov; 2011 May; 10(5):333-4. PubMed ID: 21532556
    [No Abstract]   [Full Text] [Related]  

  • 6. Michigan lab axed as Pfizer cuts costs.
    Wadman M
    Nature; 2007 Feb; 445(7127):466-7. PubMed ID: 17268437
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutting the cost of drug development?
    Rawlins MD
    Nat Rev Drug Discov; 2004 Apr; 3(4):360-4. PubMed ID: 15060531
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reaction to "About the comparison of public-private cooperation"].
    Rübsaam J
    Tijdschr Psychiatr; 2006; 48(4):343; author reply 343-4. PubMed ID: 16956001
    [No Abstract]   [Full Text] [Related]  

  • 9. Project data sphere to make cancer clinical trial data publicly available.
    Hede K
    J Natl Cancer Inst; 2013 Aug; 105(16):1159-60. PubMed ID: 23904505
    [No Abstract]   [Full Text] [Related]  

  • 10. India's drug tests.
    Padma TV
    Nature; 2005 Jul; 436(7050):485. PubMed ID: 16049471
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic possibilities of interference RNA.
    López Tricas JM
    Farm Hosp; 2012; 36(3):115-7. PubMed ID: 22137610
    [No Abstract]   [Full Text] [Related]  

  • 12. Break with tradition.
    Jayaraman KS
    Nature; 2006 Jul; 442(7101):342-3. PubMed ID: 16871181
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for drug discovery: the leading question.
    Smith A
    Nature; 2002 Jul; 418(6896):453-9. PubMed ID: 12140563
    [No Abstract]   [Full Text] [Related]  

  • 14. Remarks concerning new tools and methodologies for research and clinical practice.
    Kingston R
    Thromb Res; 2005; 117(1-2):119-21; discussion 145-51. PubMed ID: 16139871
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes research investment in the European Union.
    Halban PA; Ferrannini E; Nerup J
    Nat Med; 2006 Jan; 12(1):70-2. PubMed ID: 16397573
    [No Abstract]   [Full Text] [Related]  

  • 16. Small study on industry trial sponsorship leads to big questions about quality and bias.
    Twombly R
    J Natl Cancer Inst; 2007 Jul; 99(13):988-90. PubMed ID: 17596566
    [No Abstract]   [Full Text] [Related]  

  • 17. Discontinued drugs in 2010: oncology drugs.
    Williams R
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. China's unique position in discovery and preclinical research.
    Boutellier R; Ullman F
    Drug Discov Today; 2007 Jan; 12(1-2):4-7. PubMed ID: 17198968
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioanalysis going global.
    Chaudhary AK
    Bioanalysis; 2009 Jun; 1(3):503-5. PubMed ID: 21083144
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary: Journals must facilitate the dissemination and scrutiny of clinical research.
    Freemantle N
    BMJ; 2010 Oct; 341():c5397. PubMed ID: 20940214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.